IL37 and liver disorder: Increased circulating IL-23 concentrations are reportedly associated with metabolic dysfunction–associated steatotic liver disease (34) and LPS-induced acute liver injury (35), Therefore, these inflammatory factors contribute in a coordinated manner to activating the hepatic ERK pathway, although the involvement of additional inflammatory factors remains to be determined.